Clinical Trial Update: Intraoperative Infusion of Precedex to Reduce Length of Stay After Lumbar Spine Fusion [Phase 4]

View source ↗

Summary

Phase 4 trial assessing intraoperative infusion of dexmedetomidine (Precedex) to reduce length of stay after lumbar spine fusion; study completed with results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lumbar Intervertebral Disc Disease
• Spinal Stenosis

Drugs mentioned

• PRECEDEX (DEXMEDETOMIDINE HYDROCHLORIDE)

Snippet

Sponsor: Vanderbilt University Medical Center | Conditions: Spinal Fusion Acquired, Spinal Stenosis | Phase 4 | Status: COMPLETED | Results posted: 2018-05-25